Related Experiment Videos
Minactivin expression in human monocyte and macrophage populations
Blood
|August 1, 1985
Summary
Human monocytes and macrophages produce minactivin, a urokinase-type plasminogen activator inhibitor. Blood monocytes increase minactivin production when stimulated by muramyl dipeptide, with implications for immune response modulation.
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- Macrophages play a crucial role in immune responses and tissue homeostasis.
- Plasminogen activators are key enzymes involved in fibrinolysis and extracellular matrix remodeling.
- Minactivin is a specific inhibitor of urokinase-type plasminogen activator (uPA).
Purpose of the Study:
- To investigate the production and secretion of minactivin by various human macrophage populations.
- To determine the effect of muramyl dipeptide (adjuvant peptide) on minactivin production in blood monocytes.
- To characterize the inhibitory specificity of minactivin and its interaction with other proteases.
Main Methods:
- Adherent monolayer cultures of human blood monocytes, peritoneal macrophages, bone marrow macrophages, and colonic mucosa macrophages were established.
- Minactivin production and secretion were assessed in these cell cultures.
- Inhibitory activity of minactivin against urokinase-type plasminogen activator, trypsin, plasmin, and tissue-type plasminogen activator (tPA) was evaluated.
- The regulation of a monocyte-derived plasminogen-activating enzyme by dexamethasone was examined.
Main Results:
- All macrophage populations, except colonic mucosa macrophages, produced and secreted significant amounts of minactivin.
- Muramyl dipeptide selectively stimulated minactivin production in blood monocytes.
- Minactivin specifically inhibited urokinase-type plasminogen activator (uPA) but not trypsin, plasmin, or tissue-type plasminogen activator (tPA).
- A plasminogen-activating enzyme in monocyte cultures was found to be independent of minactivin and regulated by dexamethasone.
Conclusions:
- Human blood monocytes, peritoneal macrophages, and bone marrow macrophages are sources of minactivin.
- Blood monocytes exhibit enhanced minactivin production in response to muramyl dipeptide.
- Minactivin plays a specific role in regulating urokinase-type plasminogen activator activity within these cellular contexts.